Materialise's Leapfrog Builder Now Bundled With Leapfrog 3D

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Materialise's Leapfrog Builder Now Bundled With Leapfrog 3D Printers

LAS VEGAS, Jan. 8, 2015 (GLOBE NEWSWIRE) -- International CES -- Materialise NV (Nasdaq: MTLS ), a leading provider of Additive Manufacturing software and of sophisticated 3D printing solutions in the medical and industrial markets, and Leapfrog 3D Printers, a leading 3D printer producer from the Netherlands bringing 3D printing solutions to a wide audience, are proud that their partnership has led to a successful Builder, which will now be bundled with the new Leapfrog Creatr HS 3D printer. It is the first time that Materialise applies its decades of experience in developing high-end software to a leading desktop 3D printer. Leapfrog 3D printers are a preferred choice for business and educational users due to their deep knowledge on what these different type of users need to add value with a 3D printer. The Leapfrog Builder, which combines Materialise's Build Processor with a user-friendly front-end solution, makes printing easier than ever while still offering the user many options to print.

Much like printer drivers make inkjet printing easy because of the simple user interface that still allows the user to choose from many settings and profiles, the powerful Leapfrog Builder, developed by Materialise, enables the same for Leapfrog's 3D printers, which use fused filament fabrication (FFF) technology. This lets users adjust the settings based on pre-set, automatically updated profiles or create their own profile based on the parameters of their choice. Not only does this give users more control and options over their print, it also drastically streamlines the printing process so that users can go from STL file to clicking print in one all-inclusive program.

In order to remain agile in the rapidly developing 3D printing industry, Leapfrog 3D Printers believes in building customized solutions for their clients by building partnerships with companies that are the very best in their specific field, like Materialise. Besides these types of partnerships, Leapfrog 3D Printers also partners up with customers in different industries, to gain a deep understanding of what is needed to add value for their specific application. Their very first partnership is still holding strong: Leapfrog 3D Printers was founded in 2012 by Dutch machine producer AV Flexologic, who is still using these printers in-house. Their immediate feedback is used to continuously develop the printers, making them ideal for the education, product design, medical purposes and architectural design. The Leapfrog Builder will help tremendously in making it even easier for all types of users to print their designs.

For more information about build processors, please visit:

http://software.materialise.com/build-processor

http://www.lpfrg.com/materialiseforleapfrog

About Materialise

With its headquarters in Leuven, Belgium, and branches worldwide, Materialise is a provider of Additive Manufacturing (AM) software solutions and sophisticated 3D printing services in a wide variety of industries, including healthcare, automotive, aerospace, art and design and consumer products. Materialise has been playing an active role in the field of AM since 1990, through its involvement in AM for industrial and medical applications, by providing biomedical and clinical solutions such as medical image processing and surgical simulations and by developing unique solutions for its customers' prototyping, production, and medical needs. For additional information, please visit: www.materialise.com .

About Leapfrog 3D Printers

Leapfrog 3D printers is a producer of desktop and professional 3D printers based in The Netherlands. Our aim is to help our professional and school clients to uncover all the benefits 3D printing can offer for them. In order to do this, we work closely together with our customers, whom we treat as partners. We therefore understand that 3D printing is about much more than just the 3D printer itself; it is about the printing materials, about software, about hardware add-ons, about services and about educating the market. We call this Leapfrog Solutions: where we offer knowledge and all the tools our user groups need to add real value for their purpose. Our current solutions focus on schools, mechanical engineers and on 3D printer novices and more are on the way. Keep an eye on us, because, together with our clients, we Create the Future. Find out more through www.lpfrg.com

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements regarding, among other things, the plans, objectives, expectations, strategies and prospects of the Company, both financial and business. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words "estimate," "expect," "anticipate," "project," "plan," "intend," "believe," "forecast," "will," "may," "could," "might," "aim," "should" and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the management's current expectations. These expectations, beliefs and projections are given in good faith and management believes there is a reasonable basis for them. However, the management cannot offer any assurance that its expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. Management cautions readers that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond its control. All of the forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from expectations. Management makes no commitment, and disclaims any duty to update or revise any forward-looking statements to reflect future events or changes in its expectations.

Materialise Vanessa Palsenbarg Corporate Communications Specialist, Materialise Phone: +32 16 39 66 37 Fax: +32 16 39 66 00 Email: Twitter: @belgiancanuck or @MaterialiseNV Visit: www.materialise.com Leapfrog Saswitha de Kok Commercial manager, Leapfrog Phone: +31638763633 or +31172503625 Email: Twitter: @Leapfrog_3D Visit: www.lpfrg.com/news/press

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 42

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating NeuroOne's Q2 Financial Insights and Growth Strategies

Updated Category News Views 124

NeuroOne Prepares to Release Second Quarter Fiscal Financial Results EDEN PRAIRIE, Minn. — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is set to unveil its financial performance for the fiscal second quarter. The reporting period ended on March 31, and the results will be publicized before market activities commence on May 13. This is an exciting time for...

Continue Reading
FNB's Grand Plan for Ultra-Rich Wealth Clients

Updated Category News Views 79

FNB Corporation's New Strategy Sparks Interest Ah, the ever-competitive world of financial services targets the well-heeled once again. FNB Corporation (NYSE: FNB), headquartered in Pittsburgh, is rolling up its sleeves to offer something new for ultra-high-net-worth clientele. Outside Wall Street's dizzying chaos, this quiet yet aggressive move seems to signal they're up...

Continue Reading
Brazil Stock Market Trends and Key Indicators Update

Updated Category News Views 300

Brazil Stock Market Overview Recently, Brazil's stock market showed signs of decline, particularly on a Thursday when the Bovespa index dropped by 0.79%, reaching a new three-month low. This downturn was primarily driven by losses in critical sectors such as Public Utilities, Electric Power, and Real Estate. Investors and market analysts closely monitor these trends as...

Continue Reading
NEXN Stock Reaches New Heights Amid Positive Market Trends

Updated Category News Views 159

NEXN Stock Hits New Milestone NEXN stock has recently hit a significant milestone, reaching a price of $8.34. This impressive peak is not just a reflection of the company’s strong performance but also highlights a period filled with optimism in the market. With investors closely monitoring the stock's path, this new high may point to a potential sustained upward trend...

Continue Reading
Total Voting Rights Update from PayPoint Plc

Updated Category News Views 108

Understanding PayPoint Plc's Total Voting Rights PayPoint Plc has recently provided an update regarding its voting rights and share capital, which is crucial information for shareholders and those interested in the company. Total Share Capital Information As of August 31, 2024, PayPoint Plc's share capital consists of 72,342,171 ordinary shares, each valued at 1/3 pence....

Continue Reading